| | Type | Dynamic characteristic | Number | Cytokines | Compared to the beginning by paired -test, falling within the range at week | | | |
| | 1 | Sharp increase | 7 | TNF RII | | 2, 4, 10 | 6, 12, 16 | | CXCL8/IL8 | | 2, 4, 6, 10 | 12, 16 | | IL10 | 6, 12, 16 | 2, 4 | 10 | | CCL5/RANTES | 16 | 2, 4, 10, 12 | 6 | | CXCL4 | 6 | 2, 10, 12 | 4, 16 | | CXCL10 | 6, 16 | 2, 4, 10, 12 | | | CXCL13 | 2, 4, 6, 10, 16 | 12 | |
| | 2 | Moderate increase | 8 | IFN-gamma | | 2, 4, 12 | 6, 10, 16 | | TNF-alpha | | 2, 4, 6, 10, 16 | 12 | | GM-CSF | | 2, 4, 6, 10 | 12, 16 | | IL-1 beta | | 4, 10, 12, 16 | 2, 6 | | IL4 | | 2, 6, 12, 16 | 4, 10 | | IL17A | | 2, 4, 6 | 10, 12, 16 | | CXCL12/SDF-1 alpha | | 12, 16 | 2, 4, 6, 10 | | CD40 | 6, 10 | 4, 16 | 2, 12 |
| | 3 | Slight increase | 8 | TNF RI | | 2, 6, 16 | 4, 10, 12 | | IL2 | 6 | | 2, 4, 10, 12, 16 | | IL15 | | 2, 10 | 4, 6, 12, 16 | | IL22 | | | 2, 4, 6, 10, 12, 16 | | CCL2 | 4 | 10 | 2, 6, 12, 16 | | CCL13 | | 4, 6 | 2, 10, 12, 16 | | CCL22 | 16 | 12 | 2, 4, 6, 10 | | Galectin-3bp | | 4, 6, 12, 16 | 2, 10 |
| | 4 | A transient increase | 7 | IL6 | | 2 | 4, 6, 10, 12, 16 | | CCL18 | 2 | 4 | 6, 10, 12, 16 | | CCL27 | | | 2, 4, 6, 10, 12, 16 | | CXCL1/GRO alpha | | 4 | 2, 6, 10, 12, 16 | | CD27 | | 4, 10 | 2, 6, 12, 16 | | B7-H1/PD-L1/CD274 | 4 | | 2, 6, 10, 12, 16 | | MIF | | 12 | 2, 4, 6, 10, 16 |
| | 5 | Multipeak kinetics | 6 | IL1 RA | 6 | 16 | 2, 4, 10, 12 | | IL1 RII | | 2 | 4, 6, 10, 12, 16 | | IL23 | | 12 | 2, 4, 6, 10, 16 | | CCL4 | | | 2, 4, 6, 10, 12, 16 | | CCL7 | | 12 | 2, 4, 6, 10, 16 | | CCL11 | 4, 12 | | 2, 6, 10, 16 |
| | 6 | No specific changes | 8 | IL2 R alpha | | | 2, 4, 6, 10, 12, 16 | | IL5 | | | 2, 4, 6, 10, 12, 16 | | IL6 R alpha | | | 2, 4, 6, 10, 12, 16 | | IL19 | | | 2, 4, 6, 10, 12, 16 | | CD14 | | | 2, 4, 6, 10, 12, 16 | | CD30 | | | 2, 4, 6, 10, 12, 16 | | CD56 | | | 2, 4, 6, 10, 12, 16 | | MPO | | | 2, 4, 6, 10, 12, 16 |
|
|